The rearranged genes encoding immnunoglobulin heavy (mi) and light (K) chains specific for the hapten 2,4,6-trinitrophenyl (Tnp) were introduced into a B-lymphoma line that bears surface IgG with an unknown specificity and expresses surface Ia molecules. A transformant expressing surface IgM specific for Tnp was obtained. The transformant was found to present Tnp-proteins to antigen (protein)-specific T cells far more efficiently than the parental B-lymphoma line. This artificial-system, utilizing recombinant DNA technology and gene transfer, provides several approaches for the study of T-cell-B-cell interactions.
A T-cell-dependent immune response to a soluble antigen is generated by the collaboration of three functionally distinct immunocompetent cell populations, helper T (Th) cells, antibody-producing cells (B cells), and antigen-presenting cells (APCs) (1, 2) . Antigen presentation is a prerequisite for the generation of an immune response. A variety of APCs bearing Ia molecules on the membrane surface, including macrophages and dendritic cells, have been shown to activate Th cells by antigen presentation (3) (4) (5) . The antigen-presenting ability of macrophages has been well-documented (6) . Further, a number of experiments have established that antigenreactive Th cells recognize antigen presented in the context of Ia molecules encoded by the I region of the major histocompatibility complex (MHC). That is, Th cells and APCs must share the same haplotype of class II molecules (MHC restriction) (7) .
Recently, several investigators have turned their attention to B cells and their ability to present antigen to Th cells. Several B-lymphoma lines bearing Ia molecules, as well as normal resting B cells, have been shown to have antigenpresenting activity (8, 9) . Each clone ofB cells carries surface immunoglobulin (sIg) receptors specific for an antigen. These receptors may have an important role not only in the activation of B cells but also in the efficient presentation of antigen to T cells, as suggested by Chesnut and Grey (10) .
In a hapten-carrier system, B cells recognize haptenic determinants, whereas T cells recognize carrier determinants. By utilizing an enriched B-cell population specific for the hapten 2,4,6-trinitrophenyl (Tnp), Rock and coworkers (11, 12) showed that antigen (Tnp-modified protein) recognized by the B-cell population was presented to Th cells ( (19) . In brief, T cells were obtained by draining lymph nodes of (BALB/c x A/J)F1 mice that had been injected through the foot pad with 100 ,g of KLH. These T cells were then fused with BW5147 murine lymphoma cells. A resultant line, CAK1-22, used in the following experiments was further characterized and found to be Thy-l-positive, Lyt-2-negative, L3T4-positive, and I-Ed_ restricted. A T-cell hybridomna (3D0 18.3) that is ovalbumin (Ova)-specific and I-Ad-restricted was obtained from P. Marrack (20) . Interleukin 2 (IL-2)-dependent cell lines HT-2 and CTL.L, utilized for assessing IL-2 production by the T-cell hybridomas after antigen presentation, were maintained in RPMI 1640 medium containing 10% fetal bovine serum and 10% supernatant from concanavalin A (Con A)-stimulated rat spleen cells (21) .
Vectors and Gene Transfer. The rearranged 9fnp-and KTnp-chain genes specific for Tnp were cloned from a hybridoma (Sp6) making IgMTnp (16, 22) . The /UTnp and KTnp genes were inserted into the vector pSV2neo, which confers resistance to the antibiotic G418, a derivative of neomycin ( Escherichia coli strain K803. A protoplast fusion technique was utilized to transform the A20-2J cells with pR-HLTNP (24) . One transformant, designated A20-HL, was used for further study. Antigens and Antibodies. Hapten (Tnp) conjugates of KLH and Ova were prepared as described (25) . Tnp-Ova was calculated to carry =6 mol of Tnp per mol (43,500 g) of Ova. Tnp-KLH was calculated to bear =6 mol of Tnp per 100,000 g of KLH (25) . Culture supernatant from the B-cell hybridoma line 14-4-4S was used as a source for anti-I-Ed antibody (26) . The B-cell hybridomas MK-D6, 28-16-8S, and 34-5-3S were used as sources of anti-I-Ad antibodies (27) (28) (29) 
RESULTS
Transformation of a B-Lymphoma Line. In order to establish a cellular system in which specific antigen presentation via sIg receptor molecules can be analyzed, a cell line bearing Ia molecules is required. The B-lymphoma line A20-2J, expressing sIgG with an unknown specificity and surface Ia molecules (H-2d), was chosen as the recipient. pR-HLTNp was introduced into A20-2J cells by a modified protoplast fusion method (24) . G418-resistant transformants were screened for sIgM production by using fluorescein isothiocyanate-conjugated goat anti-mouse , antibody. One of the transformants (A20-HL) was chosen for further analysis. The parental line A20-2J secretes endogenous IgG to some extent. A Tnp-specific enzyme-linked immunosorbent assay (ELISA) revealed that the A20-HL cells secreted =200 ng of IgMTnP per ml of medium (24 hr), whereas the hybridoma line Sp603 (Fig. 2) . The A20-HL cells gave a positive signal for sIgM expression, whereas the parental A20-2J cells did not show any significant fluorescein. The idiotype of the sIgM was analyzed by using an anti-idiotypic antibody (anti-Sp603). The A20-HL cells showed a much stronger fluorescein signal than the A20-2J cells, which exhibited some background signal. This background may be due to nonspecific binding of the biotinylated anti-idiotypic antibody to the membrane surface of the A20-2J cells. These results indicate that the A20-HL cells express sIgMTnP. These cells were also stained with a biotinylated anti-I-Ad antibody Th-cell hybridoma line CAK1-22 was tested (Fig. 3A) . As a control, the original parental line A20-2J was used. Antigenpresentation activity of the A20-HL cells was saturated at 0.1 ,ug/ml, whereas A20-2J required 200 ,ug of the same antigen per ml to reach a similar saturation level. When nonmodified antigen (KLH) was utilized, both the A20-HL and A20-2J cells required higher concentrations of the antigen (250-500 ,ug/ml) to reach saturation levels (Fig. 3B) If sIgMTnp receptors were involved in specific antigen presentation, anti-Sp603 antibody should block specific antigen presentation by A20-HL. As expected, the anti-idio- typic antibody did inhibit specific antigen presentation ( Table  2) . The same treatment with the anti-idiotypic antibody did not affect antigen presentation by A20-2J.
T-cell-B-cell interactions are strictly regulated by MHC restriction; therefore, the effect of anti-Ia antibodies on antigen presentation was tested (Table 3) . CAK1-22 is I-Ed_ restricted. An anti-I-Ed antibody was shown to inhibit both specific and nonspecific antigen presentation, whereas anti-I-Ad antibodies had no significant effect. Ova-specific Th cells (3D0 18.3) are I-Ad-restricted (20) . The anti-I-Ed antibody did not block the Ova-specific antigen presentation significantly, but the anti-I-Ad antibodies abrogated the activity (data not shown). These results confirm that specific antigen presentation is mediated via Ia molecules.
The Recombinant Vector as a Universal System for Specific Antigen Presentation. We have shown that the antigen Tnp-KLH is presented to KLH-specific Th cells very efficiently.
With the appropriate choice of carrier, a wide variety of antigen-specific Th cells can be utilized. Tnp-Ova was used for antigen presentation to Ova-specific Th cells (Fig. 4) . A20-HL cells presented Tnp-Ova to Th cells -1000-fold more efficiently than did the A20-2J cells.
DISCUSSION
The recombinant vector pR-HLTNP was transfected into the B-lymphoma line A20-2J. Several experiments indicated that the resultant transformant (A20-HL) expressed IgMTnp on the membrane surface. No significant difference in expression of Ia molecules was found between the A20-HL and A20-2J cells. Since several investigators have suggested that increased expression of Ia molecules on APCs enhances antigen-presenting activity (6, 30, 31) and since the experiments presented in this paper were designed to examine the ability of sIgMTnp to present specific antigen, this observation is critical.
Antigen presentation of the hapten-carrier (Tnp-KLH) by A20-HL to the KLH-reactive, I-Ed-restricted Th hybridoma We have described use of recombinant DNA and genetransfer techniques to establish a monoclonal B-cell line bearing specific sIg receptor molecules. This system will be useful in the study of several fundamental problems in cellular immunology at the molecular level, such as antigen presentation in relation to B-cell activation, the effect of crosslinking of sIg receptors during antigen presentation, processing ofantigen, and biochemical changes in specific vs. nonspecific antigen presentation.
